Website
Sigma Healthcare LtdTelephone
61.3.9215.9215
Address
Level 6 2125 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private labels. The firm's activities include wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies, including the provision of retail support services to the branded network of pharmacy members, dose administration aid services, technology and data analytics solutions to the customers. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.61 - 1.35
Trade Value (12mth)
AU$1,336,876.00
1 week
-1.55%
1 month
-0.39%
YTD
26.37%
1 year
85.68%
All time high
2.09697
EPS 3 yr Growth
-90.900%
EBITDA Margin
1.60%
Operating Cashflow
$42m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
3.40
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
1052m
HALO Sector
Healthcare
Next Company Report Date
20-Mar-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
1.33
Date | Announcements |
---|---|
09 May 24 |
Notification regarding unquoted securities - SIG
×
Notification regarding unquoted securities - SIG |
09 May 24 |
Notification of cessation of securities - SIG
×
Notification of cessation of securities - SIG |
06 May 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
02 May 24 |
ZSP: Boral Limited to be removed from the S&P/ASX 200 Index
×
ZSP: Boral Limited to be removed from the S&P/ASX 200 Index |
29 April 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 April 24 |
Sigma Corporate Governance Statement 2024
×
Sigma Corporate Governance Statement 2024 |
29 April 24 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
29 April 24 |
Annual Review to Shareholders
×
Annual Review to Shareholders |
29 April 24 |
Appendix 4G
×
Appendix 4G |
15 April 24 |
Change in Director's Interest x 5
×
Change in Director's Interest x 5 |
10 April 24 |
Ceasing to be a substantial holder from PPT
×
Ceasing to be a substantial holder from PPT |
02 April 24 |
Change in substantial holding from HMC
×
Change in substantial holding from HMC |
26 March 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
22 March 24 |
Sigma 2024 AGM Date
×
Sigma 2024 AGM Date |
21 March 24 |
Appendix 4E & Full Year Financial Report
×
Appendix 4E & Full Year Financial Report |
21 March 24 |
Sigma Full Year 2023/24 ASX Release
×
Sigma Full Year 2023/24 ASX Release |
21 March 24 |
Sigma Full Year 2023/24 Results Presentation
×
Sigma Full Year 2023/24 Results Presentation |
21 March 24 |
Dividend/Distribution - SIG
×
Dividend/Distribution - SIG |
07 March 24 |
Sigma Full Year Results Briefing Details
×
Sigma Full Year Results Briefing Details |
05 February 24 |
Change in Director's Interest Notice x 4
×
Change in Director's Interest Notice x 4 |
01 February 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
31 January 24 |
Becoming a substantial holder from PPT
×
Becoming a substantial holder from PPT |
31 January 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
30 January 24 |
Change in substantial holding from HMC
×
Change in substantial holding from HMC |
29 January 24 |
Application for quotation of securities - SIG
×
Application for quotation of securities - SIG |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.